Renaissance Technologies’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-468,040
Closed -$16.1M 3531
2014
Q4
$16.1M Buy
+468,040
New +$15.3M 0.04% 618
2014
Q2
Sell
-125,895
Closed -$3.42M 3156
2014
Q1
$3.42M Buy
125,895
+9,995
+9% +$265K 0.01% 1466
2013
Q4
$2.4M Sell
115,900
-122,600
-51% -$2.31M 0.01% 1654
2013
Q3
$4.34M Sell
238,500
-689,700
-74% -$12.5M 0.01% 1245
2013
Q2
$15.4M Buy
+928,200
New +$14.8M 0.04% 547

Other funds holding AUXL

Renaissance Technologies's AUXL Position: Q1 2015 in Review

Renaissance Technologies sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 468,040 shares — an estimated $16.1M sold.

Renaissance Technologies first reported a position in AUXL in Q2 2013 and held it in 5 quarters. The position peaked at $16.1M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • Renaissance Technologies reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Renaissance Technologies sold 468,040 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $16.1M.
  • Renaissance Technologies first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • Renaissance Technologies's AUXILIUM PHARAMCEUTICALS INC position peaked at $16.1M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Renaissance Technologies's 13F filing for Q1 2015, filed 13 May 2015.